Dr. Bhatia and Dr. Del Rosso on treating AD

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

ISDPA: Dr. Lal on Therapeutic Updates
ISDPA: Dr. Lal on Therapeutic Updates
ISDPA Midwest Derm 2024
ISDPA: Dr. Lal on Therapeutic Updates
- Karan Lal, DO, MS, FAAD
Topical Corticosteroids and Topical Calcineurin Inhibitors in Atopic Dermatitis
Topical Corticosteroids and Topical Calcineurin Inhibitors in Atopic Dermatitis
Atopic Dermatitis
Topical Corticosteroids and Topical Calcineurin Inhibitors in Atopic Dermatitis
- Kripa Ahuja, MS
- Peter A. Lio, MD
Eczema Awareness Month
Eczema Awareness Month
Updates in Atopic Dermatitis
Eczema Awareness Month
- Peter A. Lio, MD
FDA Approves Eli Lilly’s AD Drug Ebglyss (Lebrikizumab)
FDA Approves Eli Lilly’s AD Drug Ebglyss (Lebrikizumab)
DermWire TV
FDA Approves Eli Lilly’s AD Drug Ebglyss (Lebrikizumab)

Pearls for Treating Atopic Skin